Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2257-2265

  Liu, Wei ^a   Zhai, Mingxia ^a   Wu, Zongyin ^a   Qi, Yuanming ^a   Wu, Yahong ^a   Dai, Chao ^a   Sun, Meng ^a   Li, Lu ^a   Gao, Yanfeng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Cytotoxic T lymphocyte; Epitope; Immunotherapy; PLAC1

Indexed keywords

CANCER TESTIS ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; PEPTIDE VACCINE; PLACENTA SPECIFIC 1 ANTIGEN; PROTEIN P11; PROTEIN P28; PROTEIN P31; PROTEIN P321; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN STABILITY; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CANCER VACCINES; CELL LINE, TUMOR; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; HUMANS; IMMUNIZATION; MALE; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PREGNANCY PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TESTICULAR NEOPLASMS; VACCINES, SUBUNIT;

MUS MUSCULUS;

EID: 84862759537     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0966-3     Document Type: Article

References (35)

1. EJ Bernhard AX Le JA Barbosa E Lacy VH Engelhard 1988 Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells J Exp Med 168 3 1157 1162 3262704 10.1084/jem.168.3.1157 1:STN:280:DyaL1M%2FhtVGjsw%3D%3D
2. T Boon P van der Bruggen 1996 Human tumor antigens recognized by T lymphocytes J Exp Med 183 3 725 729 8642276 10.1084/jem.183.3.725 1:CAS:528:DyaK28XhvV2rur8%3D
3. MA Cheever ML Disis H Bernhard JR Gralow SL Hand ES Huseby HL Qin M Takahashi W Chen 1995 Immunity to oncogenic proteins Immunol Rev 145 33 59 7590829 10.1111/j.1600-065X.1995.tb00076.x 1:CAS:528:DyaK2MXnsVemurw%3D
4. M Cocchia R Huber S Pantano EY Chen P Ma A Forabosco MS Ko D Schlessinger 2000 PLAC1, an Xq26 gene with placenta-specific expression Genomics 68 3 305 312 10995572 10.1006/geno.2000.6302 1:CAS:528:DC%2BD3cXmsFKlsb8%3D
5. PG Coulie V Brichard A Van Pel T Wolfel J Schneider C Traversari S Mattei E De Plaen C Lurquin JP Szikora JC Renauld T Boon 1994 A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 180 1 35 42 8006593 10.1084/jem.180.1.35 1:CAS:528:DyaK2cXlt1Kmtrs%3D
6. FX Ding F Wang YM Lu K Li KH Wang XW He SH Sun 2009 Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma Hepatology 49 5 1492 1502 19206147 10.1002/hep.22816 1:CAS:528:DC%2BD1MXlslKmur8%3D
7. XY Dong JR Peng YJ Ye HS Chen LJ Zhang XW Pang Y Li Y Zhang S Wang ME Fant YH Yin WF Chen 2008 Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients Int J Cancer 122 9 2038 2043 18183594 10.1002/ijc.23341 1:CAS:528:DC%2BD1cXkt1ChsLo%3D
8. V Dutoit V Rubio-Godoy MJ Pittet A Zippelius PY Dietrich FA Legal P Guillaume P Romero JC Cerottini RA Houghten C Pinilla D Valmori 2002 Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans J Exp Med 196 2 207 216 12119345 10.1084/jem.20020242 1:CAS:528:DC%2BD38XlsV2ms7w%3D
9. J Eguchi M Hatano F Nishimura X Zhu JE Dusak H Sato IF Pollack WJ Storkus H Okada 2006 Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses Cancer Res 66 11 5883 5891 16740728 10.1158/0008-5472.CAN-06-0363 1:CAS:528:DC%2BD28XltFyjurw%3D
10. M Fant DL Weisoly M Cocchia R Huber S Khan T Lunt D Schlessinger 2002 PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor Mol Reprod Dev 63 4 430 436 12412044 10.1002/mrd.10200 1:CAS:528:DC%2BD38XotlCgtr4%3D
11. M Fant A Farina R Nagaraja D Schlessinger 2010 PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology Prenat Diagn 30 6 497 502 20509147 1:CAS:528:DC%2BC3cXovFCltrg%3D
12. YF Gao ZQ Sun F Qi YM Qi MX Zhai HP Lou LX Chen YX Li XY Wang 2009 Identification of a new broad-spectrum CD8 + T cell epitope from over-expressed antigen COX-2 in esophageal carcinoma Cancer Lett 284 1 55 61 19423214 10.1016/j.canlet.2009.04.009 1:CAS:528:DC%2BD1MXhtVKlsLnI
13. S Gomi M Nakao F Niiya Y Imamura K Kawano S Nishizaka A Hayashi Y Sobao K Oizumi K Itoh 1999 A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs J Immunol 163 9 4994 5004 10528204 1:CAS:528:DyaK1MXmvFajtbw%3D
14. JF Han TT Zhao HL Liu ZH Lin HM Wang ZH Ruan LY Zou YZ Wu 2006 Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28 Cancer Immunol Immunother 55 12 1575 1583 16534571 10.1007/s00262-006-0152-8 1:CAS:528:DC%2BD28XptVWqsbc%3D
15. Y He L Mao Z Lin Y Deng Y Tang M Jiang W Li Z Jia J Wang B Ni Y Wu 2008 Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy Mol Immunol 45 9 2455 2464 18295890 10.1016/j.molimm.2008.01.014 1:CAS:528:DC%2BD1cXjsFOrs7c%3D
16. E Jager YT Chen JW Drijfhout J Karbach M Ringhoffer D Jager M Arand H Wada Y Noguchi E Stockert LJ Old A Knuth 1998 Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes J Exp Med 187 2 265 270 9432985 10.1084/jem.187.2.265 1:CAS:528:DyaK1cXkvVyqug%3D%3D
17. C Kesmir AK Nussbaum H Schild V Detours S Brunak 2002 Prediction of proteasome cleavage motifs by neural networks Protein Eng 15 4 287 296 11983929 10.1093/protein/15.4.287 1:CAS:528:DC%2BD38XktFWgu7w%3D
18. M Koslowski U Sahin R Mitnacht-Kraus G Seitz C Huber O Tureci 2007 A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes Cancer Res 67 19 9528 9534 17909063 10.1158/0008-5472.CAN-07-1350 1:CAS:528:DC%2BD2sXhtFSnurjM
19. E Lazoura V Apostolopoulos 2005 Rational Peptide-based vaccine design for cancer immunotherapeutic applications Curr Med Chem 12 6 629 639 15790302 10.2174/0929867053202188 1:CAS:528:DC%2BD2MXhvVeju7g%3D
20. F Li D Yang Y Wang B Liu Y Deng L Wang X Shang W Tong B Ni Y Wu 2009 Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen Cancer Immunol Immunother 58 12 2039 2049 19430788 10.1007/s00262-009-0712-9 1:CAS:528:DC%2BD1MXhtFOrsL3F
21. FF Liu XY Dong XW Pang Q Xing HC Wang HG Zhang Y Li YH Yin M Fant YJ Ye DH Shen Y Zhang S Wang WF Chen 2008 The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients Gastroenterology 134 4 998 1006 18395081 10.1053/j.gastro.2008.01.029 1:CAS:528:DC%2BD1cXls1Gmu78%3D
22. H Lv Y Gao Y Wu M Zhai L Li Y Zhu W Liu Z Wu F Chen Y Qi 2010 Identification of a novel cytotoxic T lymphocyte epitope from CFP21, a secreted protein of Mycobacterium tuberculosis Immunol Lett 133 2 94 98 20705101 10.1016/j.imlet.2010.07.007 1:CAS:528:DC%2BC3cXht1Wju7bO
23. B Mommaas J Kamp JW Drijfhout N Beekman F Ossendorp P Van Veelen J Den Haan E Goulmy T Mutis 2002 Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus J Immunol 169 6 3131 3136 12218130 1:CAS:528:DC%2BD38XntFahurg%3D
24. C Roth C Rochlitz P Kourilsky 1994 Immune response against tumors Adv Immunol 57 281 351 7872159 10.1016/S0065-2776(08)60675-6 1:CAS:528: DyaK2MXjslSmtrc%3D
25. J Ruppert J Sidney E Celis RT Kubo HM Grey A Sette 1993 Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules Cell 74 5 929 937 8104103 10.1016/0092-8674(93)90472-3 1:CAS:528:DyaK3sXms1yns7k%3D
26. N Sadanaga H Nagashima K Mashino K Tahara H Yamaguchi M Ohta T Fujie F Tanaka H Inoue K Takesako T Akiyoshi M Mori 2001 Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas Clin Cancer Res 7 8 2277 2284 11489802 1:CAS:528:DC%2BD3MXmsVOmtrg%3D
27. ML Salgaller JS Weber S Koenig JR Yannelli SA Rosenberg 1994 Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide Cancer Immunol Immunother 39 2 105 116 7519125 10.1007/BF01525316 1:CAS:528:DyaK2cXmt1yhtLw%3D
28. DE Speiser P Baumgaertner V Voelter E Devevre C Barbey N Rufer P Romero 2008 Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen Proc Natl Acad Sci U S A 105 10 3849 3854 18319339 10.1073/pnas.0800080105 1:CAS:528:DC%2BD1cXjs1Ohsrk%3D
29. TB Stuge SP Holmes S Saharan A Tuettenberg M Roederer JS Weber PP Lee 2004 Diversity and recognition efficiency of T cell responses to cancer PLoS Med 1 2 e28 15578105 10.1371/journal.pmed.0010028
30. Y Tang Z Lin B Ni J Wei J Han H Wang Y Wu 2007 An altered peptide ligand for naive cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity Cancer Immunol Immunother 56 3 319 329 16906394 10.1007/s00262-006-0195-x 1:CAS:528:DC%2BD2sXot1Sq
31. NE Tchabo P Mhawech-Fauceglia OL Caballero J Villella AF Beck AJ Miliotto J Liao C Andrews S Lele LJ Old K Odunsi 2009 Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer Cancer Immun 9 6 19705800
32. S Tourdot A Scardino E Saloustrou DA Gross S Pascolo P Cordopatis FA Lemonnier K Kosmatopoulos 2000 A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes Eur J Immunol 30 12 3411 3421 11093159 10.1002/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R 1:CAS:528:DC%2BD3MXpt1Kk
33. A Vitiello D Marchesini J Furze LA Sherman RW Chesnut 1991 Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex J Exp Med 173 4 1007 1015 1706750 10.1084/jem.173.4.1007 1:CAS:528:DyaK3MXhsVWguro%3D
34. Y Wang KJ Han XW Pang HA Vaughan W Qu XY Dong JR Peng HT Zhao JA Rui XS Leng J Cebon AW Burgess WF Chen 2002 Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies J Immunol 169 2 1102 1109 12097419 1:CAS:528:DC%2BD38XlsVWjsb0%3D
35. B Wang K Yao G Liu F Xie F Zhou Y Chen 2009 Computational prediction and identification of Epstein-Barr virus latent membrane protein 2A antigen-specific CD8 + T-cell epitopes Cell Mol Immunol 6 2 97 103 19403058 10.1038/cmi.2009.13 1:CAS:528:DC%2BC3cXjtVSmtbk%3D